IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-09-01

Reporting Person: Smith Martin Alexander (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-01	Non-Qualified Stock Option (right-to-buy)	$690.7	A	124	Acquired	2031-08-31	Common Stock (124)	Direct
2021-09-01	Incentive Stock Option (right-to-buy)	$690.7	A	588	Acquired	2031-08-31	Common Stock (588)	Direct
2021-09-01	Restricted Stock Unit	$	A	74	Acquired		Common Stock (74)	Direct

Footnotes

F1: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning September 1, 2022.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2021.

F3: Not applicable.